This study is in progress, not accepting new patients
A Study of Niraparib Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
a study on Ovarian Cancer
Ovarian Cancer PARP Inhibitor HRD HRD positive PRIMA PRIMA Clinical Trial PRIMA Study Ovarian Neoplasms Carcinoma, Ovarian Epithelial Niraparib
Lead Scientist at UCSF
- Lee-May Chen
Dr. Lee-may Chen is the Division Director and Program Director for the UCSF/KPSF Gynecologic Oncology Fellowship Program. She is deeply committed to education and improving the outcomes of gynecologic cancer care. Since 2008, I have been the director of the UCSF Gynecologic Cancer Risk Program.
- in progress, not accepting new patients
- Start Date
- Tesaro, Inc.
- Phase 3
- Study Type
- Last Updated